Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BG Medicine, Inc. (OTC: BGMD).

Full DD Report for BGMD

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-10N/A0.025N/AN/A0
2018-12-070.0210.0250.02830.02121,773
2018-12-060.021350.021350.021350.021351,800
2018-12-050.0210.021350.021350.021875
2018-12-040.0210.021350.021350.021875

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-191,2505,25023.8095Cover
2018-11-0624,03627,50287.3973Short
2018-10-251,8673,34255.8648Short
2018-10-1830,91262,63749.3510Short
2018-10-111,7001,71299.2991Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BGMD.


About BG Medicine, Inc. (OTC: BGMD)

Logo for BG Medicine, Inc. (OTC: BGMD)

BG Medicine, Inc. is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

 

Contact Information

 

 

Current Management

  • Paul Sohmer / President
  • Stephen Hall / CFO, EVP
  • Aram Adourian / Chief Scientific Officer
  • Noubar Afeyan /
  • James F. O Connor / James F. O Connor, age , has over forty years of substantive business experience covering all aspects of finance, operations, strategy and corporate development. Since , Mr. O Connor has been the principal Managing Director of The Chartwell Company, a merchant and investment banking firm. Mr. O Connor is a certified public accountant. Some of Mr. O Connor s previous directorships include: SPS Technologies , which was sold to Precision Cast Products in Color Kinetics , which was sold to Phillips Lighting Products in PC Cox Holding Ltd. and Caritas Christi Health Care System , which was sold to Cerberus Capital in . Mr. O Connor received a B.S. from Boston College and was a Rotary International Foundation Fellow at the Swiss School of Economics. Our Board concluded that Mr. O Connor should serve as a director and our Audit Committee Chairman because Mr. O Connor has extensive experience in corporate finance, accounting, operations, strategy, mergers amp acquisitions, as well as experience working on the boards of directors of public, private and nonforprofit companies.
  • Stelios Papadopoulos /
  • Paul Sohmer /
  • Harry Wilcox /

Current Share Structure

  • Market Cap: $739,162 - 03/09/2018
  • Authorized: 100,000,000 - 09/01/2015
  • Issue and Outstanding: 11,319,475 - 03/15/2016
  • Float: 9,394,980 - 09/15/2015

 



Daily Technical Chart for (OTC: BGMD)

Daily Technical Chart for (OTC: BGMD)


Stay tuned for daily updates and more on (OTC: BGMD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BGMD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BGMD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BGMD and does not buy, sell, or trade any shares of BGMD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/